A Randomized Phase III Study of Sublobar Resection (SR) versus Stereotactic Ablative Radiotherapy (SAbR) in High Risk Patients with Stage I Non-Small Cell Lung Cancer (NSCLC)

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions:
    Non-small Cell Lung Cancer
  • Age: Between 18 - 99 Years
  • Gender: Male or Female
  • Other Inclusion Criteria:

    1.  Patient must have radiographic findings consistent with non-small cell lung cancer, including lesion with ground glass opacities with a solid component of 50% or greater.


    2.  Patient must have a tumor = 4cm maximum diameter, including clinical stage IA and selected IB by PET/CT scan of the chest and upper abdomen


    3.  Patient must have tumor located peripherally within the lung, and verified by a thoracic surgeon to be in a location that will permit a sublobar resection

You may not be eligible for this study if the following are true:

  • 1.  Patients with prior intra-thoracic radiation therapy; previous chemotherapy or surgical resection specifically for the lung cancer being treated


    2.  Patients with prior lung resection on the same side

If you are registered as a volunteer, please log in to contact the study team/express interest in this study.

Contact the research team to learn more about this study.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.